Bartlett & Co’s Select Medical SEM Stock Holding History

Bartlett & Co’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52	Closed	-$1K	–	793
2021 Q3	$1K	Buy	+52	New	+$1.03K	﹤0.01%	916

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bartlett & Co's SEM Position: Q4 2021 in Review

Bartlett & Co sold out of Select Medical (SEM) in Q4 2021, closing a stake of 52 shares — an estimated $1K sold.

Bartlett & Co first reported a position in SEM in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 244 funds tracked by Wall St. Rank hold SEM as of Q4 2021.

Bartlett & Co reported no remaining Select Medical position as of Q4 2021 after selling out during the quarter.
Bartlett & Co sold 52 Select Medical shares in Q4 2021, an estimated $1K.
Bartlett & Co first reported a position in Select Medical in Q3 2021 and held it in 1 quarter.
Bartlett & Co's Select Medical position peaked at $1K in Q3 2021.
244 funds tracked by Wall St. Rank held Select Medical as of Q4 2021.

Based on Bartlett & Co's 13F filing for Q4 2021, filed 8 Mar 2022.